The pharmaceutical industry relies heavily on the precise synthesis of Active Pharmaceutical Ingredients (APIs). A critical aspect of this process involves the use of high-purity chemical intermediates. For the widely prescribed antiepileptic drug Lacosamide, one such vital intermediate is (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide, identified by CAS number 219835-31-1. Understanding the importance and sourcing of this compound is key for any pharmaceutical manufacturer.

Lacosamide is a functionalized amino acid derivative that acts as a selective enhancer of slow inactivation of voltage-gated sodium channels. Its efficacy in treating partial-onset seizures has made it a cornerstone in neurological therapy. The synthesis of Lacosamide is a multi-step process, and the quality of each intermediate directly impacts the purity, yield, and overall safety of the final API. This is where (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide plays a pivotal role.

As a chiral intermediate, its specific stereochemistry is paramount. Impurities or incorrect enantiomers can lead to reduced efficacy or, more critically, potential adverse effects in patients. Therefore, pharmaceutical companies meticulously seek out manufacturers who can guarantee high purity and consistent quality for this compound. When you are looking to buy (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide, it is essential to partner with a reputable Lacosamide intermediate manufacturer in China, a region known for its advanced chemical synthesis capabilities and competitive pricing.

Sourcing from a trusted CAS 219835-31-1 supplier ensures that the material meets stringent specifications. These typically include a white to off-white powder appearance, low loss on drying (≤1.0%), a specific melting point range (147-152°C), minimal residue on ignition (≤0.1%), and controlled heavy metal content (≤20ppm). Such precise quality control is non-negotiable in pharmaceutical production.

For procurement managers and R&D scientists, securing a stable supply chain is as important as product quality. Identifying a reliable manufacturer who can consistently deliver large quantities (e.g., in 25 kg drums) without compromising on purity is a strategic advantage. This allows for uninterrupted production schedules and cost-effective operations. When considering the price of (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide, it's important to weigh it against the assurance of quality and reliability provided by experienced manufacturers.

In conclusion, the role of high-purity intermediates like (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide cannot be overstated in the synthesis of essential medicines like Lacosamide. Pharmaceutical companies are encouraged to establish strong relationships with experienced pharmaceutical intermediate suppliers who can meet their demanding requirements for quality, consistency, and timely delivery. This collaboration is fundamental to ensuring the availability of safe and effective treatments for patients worldwide.